Accueil   Diary - News   All news Biom’up completes its Board of Directors with the nomination of Dr. Peter Byloos to support its international growth

Biom’up completes its Board of Directors with the nomination of Dr. Peter Byloos to support its international growth

 

 

 

Saint-Priest (France), September 4, 2018, 8:00 a.m. (CET) – Biom’up (the "Company"), a specialist in surgical hemostasis, today announces Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director. Dr. Byloos’ international experience in the healthcare and medical equipment sectors, combined with his knowledge of the US market will contribute additional support to Biom’up’s management team as the commercial roll-out of its lead product, HEMOBLASTTM Bellows, hits North America.

 

 

Read the press release